Commission Implementing Regulation (EU) 2019/291 of 19 February 2019 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 1-naphthylacetamide, 1-naphthylacetic acid, acrinathrin, azoxystrobin, fluazifop p, fluroxypyr, imazalil, kresoxim-methyl, oxyfluorfen, prochloraz, prohexadione, spiroxamine, tefluthrin and terbuthylazine
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act incorporated into the EEA Agreement by a Joint Committee Decision (JCD) Area (EEA Agreement)
II Technical Regulations, Standards, Testing and Certification
II.XV Dangerous Substances
Joint committee decision (JCD)
297/2019 In force in the EEA
Yes Legal documents
Commission Implementing Regulation (EU) 2019/291 of 19 February 2019 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 1-naphthylacetamide, 1-naphthylacetic acid, acrinathrin, azoxystrobin, fluazifop p, fluroxypyr, imazalil, kresoxim-methyl, oxyfluorfen, prochloraz, prohexadione, spiroxamine, tefluthrin and terbuthylazine
Framkvæmdarreglugerð framkvæmdastjórnarinnar (ESB) 2019/291 frá 19. febrúar 2019 um breytingu á framkvæmdarreglugerð (ESB) nr. 540/2011 að því er varðar framlengingu á samþykkistímabilum fyrir virku efnin 1-naftýlasetamíð, 1-naftýlediksýru, akrínatrín, asoxýstróbín, flúasífóp-p, flúroxýpýr, imasalíl, kresoxímmetýl, oxýflúorfen, próklóras, próhexadíón, spíroxamín, teflútrín og terbútýlasín
Durchführungsverordnung (EU) 2019/291 der Kommission vom 19. Februar 2019 zur Änderung der Durchführungsverordnung (EU) Nr. 540/2011 hinsichtlich der Ausweitung des Genehmigungszeitraums für die Wirkstoffe 1-Naphthylacetamid, 1-Naphthylessigsäure, Acrinathrin, Azoxystrobin, Fluazifop-P, Fluroxypyr, Imazalil, Kresoxim-methyl, Oxyfluorfen, Prochloraz, Prohexadion, Spiroxamin, Tefluthrin und Terbuthylazin
Kommisjonens gjennomføringsforordning (EU) 2019/291 av 19. februar 2019 om endring av gjennomføringsforordning (EU) nr. 540/2011 med hensyn til forlengelse av godkjenningsperioden for de aktive stoffene 1-naftylacetamid, 1-naftyleddiksyre, akrinatrin, azoksystrobin, fluazifop-P, fluroksypyr, imazalil, kresoksimmetyl, oksyfluorfen, prokloraz, proheksadion, spiroksamin, teflutrin og terbutylazin
History
14.12.2019
Adopted JCD confirmed entry into force date
14.12.2019
Compliance date in the EEA
13.12.2019
Adoption of Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement
11.09.2019
Draft Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement sent to Commission
19.02.2019
Adoption date in the EU
12.03.2019
Compliance date in the EU
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.